Showing results (301-310 of 9,974) with videos related to
Sort By:
Pageof 998
Leukemia & Lymphoma|September 23, 2011
Murine Schnurri-2 controls natural killer cell function and lymphoma developmentJunji Yamashita, Chiaki Iwamura, Kunitoshi Mitsumori, et al.Leukemia & Lymphoma|September 21, 2011
Double high-dose therapy with dose-intensive cyclophosphamide, etoposide, cisplatin (DICEP) followed by high-dose melphalan and autologous stem cell transplantation for relapsed/refractory Hodgkin lymphomaMona Shafey, Qiuli Duan, James Russell, et al.Leukemia & Lymphoma|September 21, 2011
Expression and prognostic evaluation of oxidative stress markers in an immunohistochemical study of B-cell derived lymphomasAnna Kaisa Pasanen, Hanne Kuitunen, Kirsi-Maria Haapasaari, et al.Leukemia & Lymphoma|August 5, 2011
The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and managementEliza A Hawkes, Andrew Wotherspoon, David CunninghamLeukemia & Lymphoma|August 5, 2011
Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approachesRachel E Hayden, Guy Pratt, Claudia Roberts, et al.Leukemia & Lymphoma|August 3, 2011
Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasmsVibe Skov, Thomas Stauffer Larsen, Mads Thomassen, et al.Leukemia & Lymphoma|August 11, 2011
Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemiaMark C Lanasa, Patricia H Davis, Michael Datto, et al.Leukemia & Lymphoma|September 3, 2011
Association between quality of life and clinical parameters in patients with myeloproliferative neoplasmsPeter Johansson, Ruben Mesa, Robyn Scherber, et al.Leukemia & Lymphoma|June 4, 2011
Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization systemAnamarija M Perry, Hernan Molina-Kirsch, Bharat N Nathwani, et al.Leukemia & Lymphoma|June 4, 2011
Telomere length in myelodysplastic syndromesDana E Rollison, P K Epling-Burnette, Jong Y Park, et al.Pageof 998